Medicare Enrolled

Dr. Manish Patel, MD

Hematology · Sarasota, FL
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Consulting-driven
600 N CATTLEMEN RD, Sarasota, FL 34232
9413779993
In practice since 2007 (19 years)
NPI: 1457408254 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Patel from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Patel? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Patel

Dr. Manish Patel is a hematology in Sarasota, FL, with 19 years in practice. Based on federal Medicare data, Dr. Patel performed 1,817 Medicare services across 508 unique beneficiaries.

Between the years covered by Open Payments, Dr. Patel received a total of $135,382 from 105 pharmaceutical and/or device companies across 1193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Patel is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice▲ 1,817 Medicare services$ $135,382 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,817
Medicare services
Bottom 25% in FL for hematology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
508
Unique beneficiaries
$31
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~96 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

ProcedureVolumeAvg. paidAvg. submitted
Dexamethasone injection (steroid)417$0$3
Blood draw (venipuncture)413$8$9
Complete blood count (CBC) with differential336$8$29
Office visit, established patient (30-39 min)275$94$339
Administration of chemotherapy into vein, 1 hour or less106$95$378
Office visit, established patient, complex (40-54 min)60$136$474
Office visit, established patient (20-29 min)54$66$239
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less49$21$84
Drug injection, under skin or into muscle49$11$69
Injection of additional new drug or substance into vein37$11$61
Administration of chemotherapy into vein, each additional hour21$22$79
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
2.7% high complexity
34.7% medium
62.6% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$135,382
Total received (2018-2024)
Avg $19,340/year across 7 years
Top 3% in FL for hematology
105
Companies
1,193
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$63,846 (47.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$38,065 (28.1%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$33,471 (24.7%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$22,318
2023
$14,694
2022
$16,177
2021
$23,136
2020
$4,671
2019
$19,664
2018
$34,721

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Boehringer Ingelheim International GmbH
$23,088
Daiichi Sankyo Inc.
$20,317
F. Hoffmann-La Roche AG
$9,858
Bayer HealthCare Pharmaceuticals Inc.
$9,200
EMD Serono, Inc.
$9,033
IntrinsiQ Specialty Solutions, Inc.
$8,438
PFIZER INC.
$7,779
Janssen Global Services, LLC
$6,500
Janssen Biotech, Inc.
$5,143
Exelixis Inc.
$3,282
MITSUBISHI TANABE PHARMA AMERICA, INC.
$2,940
Merck Sharp & Dohme LLC
$2,903
Incyte Corporation
$2,875
Ipsen Biopharmaceuticals, Inc
$2,219
Adaptive Biotechnologies Corporation
$2,050
Pharmacyclics LLC, An AbbVie Company
$1,640
E.R. Squibb & Sons, L.L.C.
$1,504
Celgene Corporation
$1,407
Seattle Genetics, Inc.
$1,333
AstraZeneca Pharmaceuticals LP
$1,290
Novartis Pharmaceuticals Corporation
$1,276
Lilly USA, LLC
$1,184
Genentech USA, Inc.
$852
Boehringer Ingelheim Pharma GmbH & Co.KG
$821
GENZYME CORPORATION
$599
Amgen Inc.
$583
Seagen Inc.
$527
Gilead Sciences, Inc.
$421
Merck Sharp & Dohme Corporation
$383
ARRAY BIOPHARMA INC
$374
DePuy Synthes Sales Inc.
$352
Eisai Inc.
$285
Astellas Pharma US Inc
$283
Takeda Pharmaceuticals U.S.A., Inc.
$239
Regeneron Healthcare Solutions, Inc.
$220
Kite Pharma, Inc.
$210
BeiGene USA, Inc.
$207
GlaxoSmithKline, LLC.
$191
Rigel Pharmaceuticals, Inc.
$173
JAZZ PHARMACEUTICALS INC.
$166
Boehringer Ingelheim Pharmaceuticals, Inc.
$165
Alexion Pharmaceuticals, Inc.
$137
EISAI INC.
$124
PUMA BIOTECHNOLOGY, INC.
$120
Bayer Healthcare Pharmaceuticals Inc.
$114
Puma Biotechnology, Inc.
$101
SOBI, INC
$99
Epizyme, Inc.
$96
Foundation Medicine, Inc.
$93
CTI BioPharma Corp.
$93
Helsinn Therapeutics (U.S.), Inc.
$88
Janssen Pharmaceuticals, Inc
$84
Mirati Therapeutics, Inc.
$82
Janssen Scientific Affairs, LLC
$81
Deciphera Pharmaceuticals Inc.
$80
Sumitomo Pharma America, Inc.
$69
MorphoSys, US Inc.
$67
TerSera Therapeutics LLC
$62
ABBVIE INC.
$62
Kyowa Kirin, Inc.
$61
Stemline Therapeutics Inc.
$57
ModernaTX, Inc.
$56
Blueprint Medicines Corporation
$56
Sobi, Inc
$53
Karyopharm Therapeutics Inc.
$46
Pharmacyclics LLC, an AbbVie Company
$46
Agios Pharmaceuticals, Inc.
$46
Sysmex Inostics Inc
$43
Acrotech Biopharma LLC
$42
Taiho Oncology, Inc.
$41
Jazz Pharmaceuticals Inc.
$39
Dova Pharmaceuticals
$39
Heron Therapeutics, Inc.
$39
Genentech, Inc.
$38
INSYS Therapeutics Inc
$36
ADC Therapeutics America, Inc.
$35
Servier Pharmaceuticals LLC
$35
Aveo Pharmaceuticals, Inc.
$34
Pharmacosmos Therapeutics Inc.
$34
TAIHO ONCOLOGY, INC.
$33
AbbVie Inc.
$32
SpringWorks Therapeutics, Inc.
$32
Alnylam Pharmaceuticals Inc.
$31
TESARO, Inc.
$29
GT Medical Technologies, Inc
$29
Clovis Oncology, Inc.
$28
SERVIER PHARMACEUTICALS LLC
$27
Spectrum Pharmaceuticals Inc.
$27
Sun Pharmaceutical Industries Inc.
$25
Myovant Sciences Inc.
$24
RECORDATI_RARE_DISEASES_INC.
$21
Epizyme, Inc.,
$20
PharmaEssentia USA Corporation
$17
Sirtex Medical Inc
$17
Legend Biotech USA Inc.
$16
GE HEALTHCARE
$16
Array BioPharma Inc.
$15
Partner Therapeutics, Inc.
$15
TG THERAPEUTICS, INC.
$15
TG Therapeutics, Inc.
$15
Immunomedics, Inc.
$14
Lexicon Pharmaceuticals, Inc.
$13
Boston Scientific Corporation
$12
Aurobindo Pharma USA, Inc.
$11
Shire North American Group Inc
$11
Top 3 companies account for 39.3% of total payments
Associated products mentioned in payments ›
ACTIS · ADAKVEO · ADCETRIS · AFINITOR · AKYNZEO · ALIMTA · ATTUNE · AYVAKIT · Abraxane · Alecensa · Aliqopa · Avastin · BALVERSA · BAVENCIO · BELEODAQ · BESREMI · BLENREP · BOSULIF · BRAFTOVI · BRUKINSA · Bavencio · Blincyto · Braftovi · CABLIVI · CABOMETYX · CALQUENCE · CEREZYME · CINVANTI · CYRAMZA · Cabometyx · DARZALEX · DOPTELET · Doptelet · ELITEK · ELREXFIO · EMPLICITI · ENHERTU · ENJAYMO · Enhertu · Erleada · FOTIVDA · FOUNDATIONONE · FRUZAQLA · Fabhalta · Folotyn · GAUCHER-DISEASE · GAZYVA · GILOTRIF · GIVLAARI · GammaTile · HEMADY · IBRANCE · IMBRUVICA · IMFINZI · INFLECTRA · INFUGEM · INJECTAFER · INLYTA · INREBIC · Imbruvica · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LUMAKRAS · LYNPARZA · Lenvima · Leukine · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · MYLOTARG · NERLYNX · NINLARO · Nerlynx · Neulasta · Nexavar · Non-Covered Product · Nplate · Nubeqa · OGSIVEO · OJJAARA · ONUREG · OPDIVO · OPDUALAG · ORGOVYX · Onivyde · Orserdu · PADCEV · PANHEMATIN · PEMAZYRE · PIQRAY · PLAVIX · PLUVICTO · POTELIGEO · PROMACTA · PYRUKYND · Padcev · Perjeta · Pomalyst · Poteligeo · Prolia · QINLOCK · Quzyttir · REBLOZYL · RETACRIT · RETEVMO · RYBREVANT · Revlimid · Rezlidhia · Rituxan Hycela · Rubraca · SANDOSTATIN · SANDOSTATIN LAR · SARCLISA · SCEMBLIX · SHINGRIX · SIR-Spheres Microspheres · SOMATULINE DEPOT · SPRYCEL · SUSTOL · SUTENT · SYNDROS · Somatuline Depot · Stivarga · TABRECTA · TAFINLAR · TAGRISSO · TASIGNA · TAZVERIK · TECVAYLI · TIBSOVO · TUKYSA · Tavalisse · Tazverik · Tibsovo · Trodelvy · UKONIQ · ULTOMIRIS · Ultomiris · VENCLEXTA · VERZENIO · VONVENDI · VOTRIENT · VYXEOS · Varithena Administration Pack · Velys · Vonjo · XALKORI · XARELTO · XOSPATA · XPOVIO · XTANDI · Xermelo · Xospata · Xtandi · Yescarta · ZEJULA · ZEPZELCA · ZEVALIN · ZOLADEX · ZYKADIA · ZYTIGA · Zelboraf · Zevalin · clonoSEQ
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (47%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 3% for hematology in FL.

Equivalent to $7,451 per 100 Medicare services performed
Looking for a hematology in Sarasota?
Compare hematologys in the Sarasota area by procedure volume, costs, and industry payment transparency.
Browse hematologys nearby

Geographic Context

Hematologys within 10 mi
22
Per 100K population
4.9
County median income
$80,633
Nearest hospital
HCA FLORIDA SARASOTA DOCTORS HOSPITAL
3.1 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data Medicare Util.Annual (CY lag)
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Patel is a clinical cardiology specialist, with moderate Medicare volume, and high industry engagement (consulting-driven, top 3%), with 19 years of practice experience.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Patel experienced with dexamethasone injection (steroid)?
Based on Medicare claims data, Dr. Patel performed 417 dexamethasone injection (steroid) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Patel receive payments from pharmaceutical companies?
Yes. Dr. Patel received a total of $135,382 from 105 companies across 1,193 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Patel's costs compare to other hematologys in Sarasota?
Dr. Patel's average Medicare payment per service is $31. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Patel) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →